Literature DB >> 33649769

Race, Genetic Admixture, and Cognitive Performance in the Cuban Population.

Jorge J Llibre-Guerra1,2, Yan Li1, Isabel Elaine Allen3, Juan C Llibre-Guerra4, Ana M Rodríguez Salgado2, Ana Ibis Peñalver5, Arianna Almirall Sanchez2, Jennifer S Yokoyama2,6, Lea Grinberg2,6, Victor Valcour2,6, Bruce L Miller2,6, Juan J Llibre-Rodríguez7.   

Abstract

BACKGROUND: Population aging will lead to a dramatic increase in dementia prevalence, which will disproportionally affect racial minorities. The presence of racial differences in dementia prevalence has been widely reported in United States, but there are no relevant studies on this topic in low- and middle-income countries.
METHODS: In a cross-sectional survey, 2944 older Cubans were recruited at a community-based level aimed to identify the effects of self-identified race and genetic admixture on cognitive performance. Dementia diagnosis was established using 10/66 Dementia and DSM-IV criteria. APOE-ε4 genotype was determined in 2511 (85%) and genetic admixture was completed for all dementia cases and in a randomly selected sample of cognitive healthy participants (218 dementia cases and 367 participants without dementia).
RESULTS: The overall prevalence of dementia was 8.7%, without large or statistically significant differences on dementia prevalence (p = .12) by self-identified race. Mean cognitive scores were similar across racial groups (p = .46). After controlling for age, sex, and education, greater proportion of African ancestry was not associated with cognitive performance (p = .17).
CONCLUSIONS: We found no evidence of an independent effect of self-identified race and/or population ancestry on dementia prevalence or cognitive performance. This suggests that observed differences in dementia prevalence among diverse populations may be driven primarily by social determinants of health.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; Ancestry background; Cognitive aging

Mesh:

Year:  2022        PMID: 33649769     DOI: 10.1093/gerona/glab063

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  4 in total

1.  Promoting Health Equity Across the Life Span.

Authors:  Michelle C Odden; Roland J Thorpe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-02-03       Impact factor: 6.053

2.  Evaluating the Impact and Rationale of Race-Specific Estimations of Kidney Function: Estimations from U.S. NHANES, 2015-2018.

Authors:  Jennifer W Tsai; Jessica P Cerdeña; William C Goedel; William S Asch; Vanessa Grubbs; Mallika L Mendu; Jay S Kaufman
Journal:  EClinicalMedicine       Date:  2021-11-19

Review 3.  Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.

Authors:  Sanne Franzen; Jade Emily Smith; Esther van den Berg; Monica Rivera Mindt; Rozemarijn L van Bruchem-Visser; Erin L Abner; Lon S Schneider; Niels D Prins; Ganesh M Babulal; Janne M Papma
Journal:  Alzheimers Dement       Date:  2021-09-30       Impact factor: 16.655

4.  Associations between education and dementia in the Caribbean and the United States: An international comparison.

Authors:  Jing Li; Jorge J Llibre-Guerra; Amal Harrati; Jordan Weiss; Ivonne Z Jiménez-Velázquez; Daisy Acosta; Juan de Jesús Llibre-Rodriguez; Mao-Mei Liu; William H Dow
Journal:  Alzheimers Dement (N Y)       Date:  2021-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.